The development of a systemic mycosis, which often follows long-lasting antibiotic or immunosuppressive therapy creates many difficult diagnostic and therapeutic problems for the clinician. We had the opportunity to observe several cases in which a systemic candidal mycosis was either suspected or proven. In view of the severity of the clinical picture we decided upon antimycotic therapy with miconazole.
This drug was chosen because of its antimycotic effect upon candida species and because experience to date has shown that it is practically free of toxicity and that it can also be administered intravenously.
The clinical details of those patients whom we have treated with miconazole, are given in Table 1 .
Case 1 36-year-old female, admitted to hospital because of an E. coli septicemia. She was given high doses of antibiotics. After 5 weeks of treatment she developed a candida septicamia. Therapy with miconazole was carried out over a 15-day period and the patient received a total amount of 8.8 g. The clinical development of the treatment is shown in Fig 1. Case 2 72-year-old man, admitted because of a diabetes mellitus and multiple abcesses. In the course of antibiotic treatment he also developed a candidal septiczmia, which was treated over a 12-day period with a total dose of 12.4 g of miconazole. Unfortunately the patient died from a stroke before the treatment was finished.
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Case 3 73-year-old man, admitted because of urosepticemia and treated with high dose of antibiotics. Although at first his condition had improved, on the twenty-fifth day after admission he also developed a candidal septicemia, which was treated over an 1 1-day period with a total dose of 6.6 g of miconazole. The clinical course of the treatment is shown in Fig 2. Case 4 65-year-old woman, treated for the suspected diagnosis of fungal pneumonia over a period of 42 days with a total dose of 29.2 g of miconazole. The diagnosis was suspected on the grounds of the chest X-ray as well as the isolation of candidal species from bronchial secretions obtained during bronchoscopy.
The clinical condition of the patient did not improve and she died ater a few weeks of respiratory insufficiency. Autopsy revealed a stomach cancer which had metastasized diffusely to the lungs. The clinical diagnosis of a fungal pneumonia had thus been proven to be false. We have listed this patient because we thought it of interest to see that even prolonged treatment with miconazole is tolerated without any side-effects. Case 5 40-year-old woman, admitted to an outlying hospital because of septicaemia and a haemolytic anxmia. She was treated for a suspected diagnosis of a candidal septicamia, because of a concurrent urinary tract infection caused by C. albicans, for a 39-day period with a total dose of 31.8 g of miconazole.
Candidal speticemia was not proven with absolute certainty in this patient, but she made an uneventful recovery. Fig 1 shows the clinical course of the miconazole therapy for the first patient. Approximately 36 hours after the beginning of the therapy her body temperature had normalized. From this point on the patient remained afebrile and blood cultures for fungi were negative. Fig 2 shows the clinical course of the third patient under miconazole therapy. Immediately after the institution of miconazole therapy the temperature normalized for about 2 days. The further course of the treatment was complicated by renewed appearance of a urinary tract infection, which the patient possibly acquired as a consequence of urologic instrumentation. The blood cultures during and after miconazole therapy were none the less negative and the patient eventually had no more fever.
Miconazole was given either as an infusion in 250 ml of saline over a one-hour period or as a slow single intravenous injection. None of the patients complained about difficulties, such as pain at the site of injection or nausea.
Laboratory examinations (Table 2) showed no clear-cut side-effects which could be attributed to miconazole. The two patients who have died, did so from their respective underlying disease. Attention should be drawn to the platelet counts in the third and fourth patients. In both patients we recorded an increase of thrombocytes and in the third case there was even a thrombocytosis. This could have been a side-effect of the miconazole therapy. But after examination of the patients' charts it was found that both patients had been treated with cephalotin, which is known occasionally to lead to thrombocytosis. Table 3 shows that a deterioration of the renal function was observed in only one case. This was probably due to a progressive deterioration of the patient's general condition. It was noted that this patient died from a stroke. Table 3 Laboratory data (kidney function) Table 4 shows that in the case of the first patient there was a slight increase of the SGPT from 10 to 22 iu. However, because this value was in the normal range we do not consider that these results demonstrate any toxic hepatic effect of miconazole.
Our experiences confirm the finding that miconazole can be safely administered by intravenous injection, that the drug is effective in the treatment of candidal septicwmia and that it is remarkably free from toxic side-effects. DISCUSSION Professor Vanbreuseghem (Chairman) asked Dr Deppermann whether he was satisfied with his diagnosis of candidiasis solely on the basis of the septicwmic condition, bearing in mind that only that morning they had heard that this was not accepted as sufficient proof. Dr Deppermann recalled Professor Stille's report of at least 2 cases of candidal septicaemia which had been cured spontaneously after the infecting venous catheter had been withdrawn. All their patients had venous catheters, and some septicemia may have disappeared even without miconazole if the catheters had been withdrawn. But one patient continued to be septicaemic even after its withdrawal, so Dr Deppermann could not suggest that in all cases the catheter alone was the route of entry of candida.
Professor W Stille (Frankfurt) pointed out that even if septicemia could be cleared in 90% of cases by removal of the catheter in general it was not only the infection that was to be treated. The possibility of complications must also be treated. There could be septicaemic complications after candidal septicwmia, therefore, it was necessary to carry out the treatment. Professor Vanbreuseghem (Chairman) agreed, but said it was difficult to speak of systemic candidiasis. It was better to consider the eventual septicemia and nothing else. Dr Deppermann was asked whether any of those treating candidal septicemia observed the ocular fundus to see whether there were any candidal lesions there and whether miconazole would prevent or cure those lesions. He replied that they routinely observed the fundus, but no changes were reported.
